Pentablock Copolymer Micelles for mRNA and Zwitterionic Agent Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current polymeric micellar systems face challenges in efficiently encapsulating water-soluble agents and maintaining stability under physiological conditions, leading to poor loading efficiency and cytotoxicity issues for zwitterionic agents and mRNA delivery.
Innovation Solution
A polymeric micelle complex comprising pentablock copolymers with pendant moieties forming a hydrophobic core and hydrophilic layer, allowing zwitterionic agents or mRNA to bind electrostatically, enhancing encapsulation and stability for targeted intracellular delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If classical polymeric micelles are used to encapsulate water-soluble agents, then the micelle structure is simple and easy to manufacture, but the encapsulation efficiency is poor
Solution Approach 1:
The patent employs pentablock copolymers comprising five distinct blocks (A-B-C-D-E) with specific functionalities: blocks A and E provide electrostatic interactions through charged pendant moieties, blocks B and D form hydrophobic domains for drug incorporation, and block C provides hydrophilic corona for stability. This composite structure enables simultaneous encapsulation of both hydrophobic and hydrophilic drugs, resolving the contradiction between structural simplicity and encapsulation efficiency.
Solution Approach 2:
The patent applies local quality by assigning different functional properties to different blocks within the copolymer: the charged blocks (A and E) provide electrostatic binding sites, the poly(alkylene oxide) blocks (B, C, D) provide hydrophobic/hydrophilic regions, and the pendant moieties provide specific interaction sites. This spatial differentiation of properties enables multi-functional encapsulation capabilities while maintaining a systematic structure.
2Duration of action of moving object
If polymeric micelles are used for drug delivery, then circulation half-life is enhanced, but stability under physiological conditions deteriorates
Solution Approach 1:
The patent utilizes parameter changes by designing the pentablock copolymer with specific molecular weights, charge densities, and hydrophobic/hydrophilic ratios that enable the micelles to maintain structural integrity at physiological pH and temperature while circulating. The charged pendant moieties and poly(alkylene oxide) blocks work synergistically to provide both prolonged circulation and physiological stability.
3Quantity of substance
If polymeric micelles encapsulate zwitterionic agents, then loading capacity increases, but cytotoxicity increases
Solution Approach 1:
The patent employs the charged pendant moieties and hydrophilic blocks as intermediaries that mediate between the zwitterionic drugs and the cellular environment. These intermediary structures provide electrostatic shielding and steric protection, enabling high drug loading while reducing direct cytotoxic effects on cells.
4Productivity
If water-soluble agents are encapsulated in polymeric micelles, then delivery to target site is improved, but encapsulation efficiency deteriorates
Solution Approach 1:
The patent achieves universality by designing the pentablock copolymer to perform multiple functions simultaneously: blocks A and E provide electrostatic binding for water-soluble agents, blocks B and D provide hydrophobic domains for lipid-soluble agents, the poly(alkylene oxide) blocks provide steric stabilization, and the overall structure enables targeted delivery. This multi-functional design allows efficient encapsulation of diverse agents while maintaining targeted delivery capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymeric micelle complex improves the loading efficiency and stability of zwitterionic agents and mRNA, facilitating effective intracellular delivery and reducing cytotoxicity, thereby addressing the limitations of existing systems.
Implementation Method 1
mRNA binds with the pendant moieties in the polymeric micelle based on electrostatic interactions
Implementation Method 2
amphiphilic copolymers in aqueous medium undergo micellization by aggregation of their hydrophobic domains
Implementation Method 3
Polymeric micelles are formed by spontaneous self-assembly of amphiphilic copolymers
Data Source
AI summary
The disclosure provides compositions of polymeric micelle complexes, as well as methods for preparing such compositions. Such compositions are suitable for pharmaceutical delivery of rnRNA or one or more zwitterionic agents to cell interior, and can be used in therapy and/or diagnosis, for example, for treating cancer, inflammation, microbial and viral infections, and metabolic disorders, as well as other diseases.